Start a conversation Expert offering 01
See the opportunity, the evidence, and the risk clearly.
An integrated assessment of an asset, licensing opportunity, acquisition, investment, or partnership—translated into a decision-ready recommendation.
The problem
Promising science can conceal clinical, regulatory, statistical, safety, quality, manufacturing, or commercial risks that materially change asset value. A data-room summary alone cannot show whether the development path is achievable or the opportunity is truly differentiated.
The HEOS solution
HEOS brings together the cross-functional expertise required for the asset—including clinical development, regulatory strategy, safety, biostatistics, quality assurance, manufacturing and CMC, Medical Affairs, market access, and commercialization—to test the evidence and define the conditions for success.
How we do it
Senior experts work from assessment through execution, with clear decisions, accountable actions, and measurable outcomes.
Review the scientific rationale, clinical evidence, safety profile, development plan, regulatory history, quality and manufacturing readiness, competitive landscape, and commercial assumptions.
Identify evidence gaps, hidden dependencies, target-label constraints, execution risks, value inflection points, and the questions that must be resolved.
Translate the integrated analysis into a clear recommendation, conditions for proceeding, priorities for negotiation, and a practical path forward.
What you get
How success is measured
The finish line
Cross-functional expertise. Better decisions.
Tell us what you are evaluating, building, or preparing to execute. HEOS will assemble the right expertise around the work.